Anabolic androgenic steroids and the brain: Novel actions at the GABAA receptor and on GABAA receptor- mediated behaviors

Neurosteroid Effects in the Central Nervous System: The Role of the GABA-A Receptor

Volumn , Issue , 2003, Pages 119-141

  Clark, Ann S ^a   Jones, Brian L ^b   Yang, Paul ^b   Henderson, Leslie P ^b  

^a Dartmouth College   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85031056372     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (96)

1. Blue, J.G. and Lombardo, J.A., Nutritional aspects of exercise: steroids and steroidlike compounds, Clin. Sports Med., 8, 667, 1999.
2. Basaria, S., Wahlstrom, J.T., and Dobs, A.S., Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases, J. Clin. Endocrinol. Metab., 86, 5108, 2001.
3. Shahidi, N.T., A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids, Clin. Ther., 23, 1355, 2001.
4. Wilson, J., Androgen abuse by athletes, Endocr. Rev., 9, 181, 1988.
5. Lukas, S.E., CNS effects and abuse liability of anabolic-androgenic steroids, Annu. Rev. Toxicol., 36, 333, 1996.
6. Kammerer, R.C., Drug testing and anabolic steroids, in Anabolic Steroids in Sport and Exercise, Yesalis, C.E., Ed., Human Kinetics, Champaign, IL, 2000, chap. 13.
7. Bahrke, M.S., Yesalis, C.E., and Wright, J.E., Psychological and behavioral effects of endogenous testosterone and anabolic-androgenic steroids, Sports Med. 22, 367, 1996.
8. Friedl, K.E., Effects of anabolic steroids on physical health, in Anabolic Steroids in Sport and Exercise, Yesalis, C.E., Ed., Human Kinetics, Champaign, IL, 2000, chap. 6.
9. Franke, W.W. and Berendonk, B., Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government, Clin. Chem., 43, 1262, 1997.
10. Bowers, L.D. and Segura, J., Anabolic steroids, athletic drug testing, and the Olympic games, Clin. Chem., 42, 999, 1996.
11. Yesalis, C.E., Kennedy, N.J., Kopstein, A.N., and Bahrke, M.S., Anabolic-androgenic steroid use in the United States, JAMA, 270, 1217, 1993.
12. Kolata, G., With No Answers on Risks, Steroid Users Still Say ‘Yes,’ New York Times, December 2, 2002, p. 1-19.
13. NIDA Research Report Series, http://165.112.78.61/ResearchReports/Steroids/Anabolicsteroids. html; 2002.
14. Yesalis, C.E., Barsukiewicz, C.K., Kopstein, A.N., and Bahrke, M.S., Trends in anabolic-androgenic steroid use among adolescents, Arch. Pediatr. Adolesc. Med., 151, 1197, 1997.
15. Bahrke, M.S., Yesalis, C.E., and Brower, K.J., Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents, Child Adolesc. Psychiatr. Clin. N. Am., 7, 821, 1998.
16. Koch, J.J., Performance-enhancing substances and their use among adolescent athletes, Pediatr. Rev., 23, 310, 2002.
17. Rubinow, D.R. and Schmidt, P.J., Androgens, brain and behavior, Am. J. Psychiatry, 153, 974, 1996.
18. Korkia, P. and Stimson, G.V., Indications of prevalence, practice and effects of anabolic steroid use in Great Britain, Int. J. Sports Med., 18, 557, 1997.
19. Kuhn, C.M., Anabolic steroids, Recent Prog. Horm. Res., 57, 411, 2002.
20. Martini, L., The 5α-reduction of testosterone in the neuroendocrine structures: biochemical and physiological implications, Endocr. Rev., 3, 1, 1982.
21. Winters, S., Androgens: endocrine physiology and pharmacology, NIDA Res. Monogr., 102, 113, 1990.
22. Kochakian, C. and Yesalis, C.E., Anabolic-androgenic steroids: a historical perspective and definition, in Anabolic Steroids in Sport and Exercise, Yesalis, C.E., Ed., Human Kinetics, Champaign, IL, 2000, chap. 1.
23. Ryan, K.J., Biological aromatization of steroids, J. Biol. Chem., 234, 268, 1959.
24. Papaconstantinou, C.D., Umbreit, T.H., Goering, P.L., and Brown, K.M., Effects of 17α-methyltestosterone on uterine morphology and heat shock protein expression are mediated through estrogen and androgen receptors, J. Steroid Biochem. Mol. Biol., 82, 305, 2002.
25. de Gooyer, M.E. et al., Tibolone is not converted by human aromatase to 7α-methyl-17α-ethynylestradiol (7α-MEE): analyses with sensitive bioassays for estrogens and androgens with LC-MSMS, Steroids, 68, 235, 2003.
26. A receptor complex by steroids in slices of rat cuneate nucleus, Br. J. Pharmacol., 96, 409, 1989.
27. A receptor function, Trends Pharmacol. Sci., 16, 295, 1995.
28. A receptors, Int. Rev. Neurobiol., 46, 177, 2001.
29. Gee, K.W. et al., Steroid modulation of the chloride ionophore in rat brain: structurereactivity requirements, regional dependence and mechanisms of action, J. Pharmacol. Exp. Ther., 246, 803, 1988.
30. Purdy, R.H., Morrow, A.L., Blinn, J.R., and Paul, S.M., Synthesis metabolism, and pharmacological activity of 3α-hydroxy steroids which potentiate GABA-receptormediated chloride uptake in rat cerebral cortical synaptoneurosomes, J. Med. Chem., 33, 1572, 1990.
31. Clark, A.S. and Henderson, L.P., Behavioral and physiological responses to anabolicandrogenic steroids, Neurosci. Biobehav. Rev., in press.
32. Fernandez-Guasti, A., Larsson, K., and Beyer, C., GABAergic control of masculine sexual behavior, Pharmacol. Biochem. Behav., 24, 1065, 1986.
33. Ojeda, S.R. and Urbanski, H.F., Puberty in the rat, in The Physiology of Reproduction, Vol. 2, Knobil, E. and Neill, J.D., Eds., Raven Press Ltd., New York, 1994, chap 40.
34. McCarthy, M.M., Frank A. Beach Award. Functional significance of steroid modulation of GABAergic neurotransmission: analysis at the behavioral, cellular, and molecular levels, Horm. Behav., 29, 131, 1995.
35. Miczek, K.A., Fish, E.W., De Bold, J.F., and De Almeida, R.M.M., Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and γ-aminobutyric acid systems, Psychopharmacology, 163, 434, 2002.
36. Wilson, M.A., GABA physiology: modulation by benzodiazepines and hormones, Crit. Rev. Neurosci., 10, 1, 1996.
37. Siegel, A., Roeling, T.A., Gregg, T.R., and Kruk, M.R., Neuropharmacology of brainstimulation- evoked aggression, Neurosci. Biobehav. Rev., 23, 359, 1999.
38. Masonis, A.E. and McCarthy, M.P., Direct effects of the anabolic/androgenic steroids, stanozolol and 17α-methyltestosterone, on benzodiazepine binding to the γ-aminobutyric acid A receptor, Neurosci. Lett., 189, 35, 1995.
39. 35S]TBPS binding, J. Pharmacol. Exp. Ther., 279, 186, 1996.
40. A receptor-mediated currents in the rat forebrain, J. Neurophysiol., 83, 3299, 2000.
41. A receptors, Neuropharmacology, 43, 619, 2002.
42. A receptor subunit mRNAs in the mouse forebrain, Neuropharmacology, 43, 634, 2002.
43. Betz, H., Ligand-gated ion channels in the brain: the amino acid receptor superfamily, Neuron, 5, 383, 1990.
44. Boyd, R.T., The molecular biology of neuronal nicotinic acetylcholine receptors, Crit. Rev. Toxicol., 27, 299, 1997.
45. Betz, H. et al., Structure and functions of inhibitory and excitatory glycine receptors, Ann. N.Y. Acad. Sci., 868, 667, 1999.
46. Jackson, M.B. and Yakel, J.L., The 5-HT3 receptor channel, Ann. Rev. Physiol., 57, 447, 1995.
47. A receptors, Brain Res. Rev., 29, 196, 1999.
48. Whiting, P.J., The GABA-A receptor gene family: new targets for therapeutic intervention, Neurochem. Int., 34, 387, 1999.
49. Whiting, P. et al., Molecular and functional diversity of the expanding GABA-A receptor gene family, Ann. N.Y. Acad. Sci., 868, 645, 1999.
50. 2 subunit, one of which contains a protein kinase C phosphorylation site, Proc. Natl. Acad. Sci. U.S.A., 87, 9966, 1990.
51. 2- subunit in mice by alternative splicing, J. Neurochem., 56, 713, 1991.
52. A receptor, J. Biol. Chem. 267, 14470, 1992.
53. 2 subunit, J. Neurochem., 62, 10, 1994.
54. A receptor, Mol. Brain Res., 28, 175, 1995.
55. 3 subunit (GABRB3), J. Biol. Chem., 268, 4420, 1993.
56. A receptor function, J. Neurochem., 63, 1167, 1994.
57. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits, J. Comp. Neurol., 359, 154, 1995.
58. A receptors: classification on the basis of subunit structure and receptor function, Pharmacol. Rev., 50, 291, 1998.
59. A/benzodiazepine receptors, J. Neurochem., 63, 1466, 1994.
60. 1 does not exist in combination with another γ-subunit, Mol. Pharmacol., 45, 1061, 1994.
61. Sieghart, W., Structure and pharmacology of γ-aminobutyric acidA receptor subtypes, Pharmacol. Rev., 47, 181, 1995.
62. A receptors in the rat, Horm. Behav., 27, 568, 1993.
63. A receptor-gated chloride ion transport, Life Sci., 58, 573, 1996.
64. Wu, F.C., Endocrine aspects of anabolic steroids, Clin. Chem., 43, 1289, 1997.
65. A receptor channels of mouse spinal cord neurones in culture, J. Physiol. (Lond.), 475, 69, 1994.
66. A receptor microscopic affinity, Neuropharmacology, 35, 1383, 1996.
67. A receptors in cultured murine cerebellar granule cells, J. Physiol. (Lond.), 503, 353, 1997.
68. A channel deactivation by altering kinetics of desensitized states, J. Neurosci., 17, 4022, 1997.
69. A channel responses to brief agonist pulses, Neuron, 15, 181, 1995.
70. Jones, M.V. and Westbrook, G.L., The impact of receptor desensitization on fast synaptic transmission, Trends Neurosci., 19, 96, 1996.
71. A receptors containing the delta subunit, J. Neurosci., 22, 1541, 2002.
72. A receptors in neurons expressing γ1 subunit mRNA in the preoptic area of the rat, J. Neurophysiol., 81, 192, 1999.
73. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon, J. Neurosci., 12, 1040, 1992.
74. A receptors: immunocytochemical distribution of 13 subunits in the adult rat brain, Neuroscience, 101, 815, 2000.
75. A receptor subunit mRNA expression in preoptic area and bed nucleus of the stria terminalis of female rat brain, J. Neurosci., 15, 2328, 1995.
76. 2 subunit is upregulated by testosterone in rat cerebral cortex, Neurosci. Lett., 265, 25, 1999.
77. Woods, J.H., Katz, J.L., and Winger, G., Benzodiazepines: use, abuse and consequences, Pharmacol. Rev., 44, 151, 1992.
78. Möhler, H., Fritschy, J.M., and Rudolph, U., A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther., 300, 2, 2002.
79. Romeo, E. et al., Marked decrease of plasma neuroactive steroids during alcohol withdrawal, Clin. Neuropharmacol., 19, 366, 1996.
80. Morrow, A.L., VanDoren, M.J., Penland, S.N., and Matthews, D.B., The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence, Brain Res. Rev., 37, 98, 2001.
81. Bing, O. et al., High doses of testosterone increase anticonflict behaviour in rat, Eur. Neuropsychopharmacol., 8, 321, 1998.
82. Aikey, J.L., Nyby, J.G., Anmuth, D.M., and James, P.J., Testosterone rapidly reduces anxiety in male house mice (Mus musculus), Horm. Behav. 42, 448, 2002.
83. Fish, E.W., De Bold, J.F., and Miczek, K.A., Aggressive behavior as a reinforcer in mice: activation by allopregnanolone, Psychopharmacology, 163, 459, 2002.
84. Lumia, A.R., Thorner, K.M., and McGinnis, M.Y., Effects of chronically high doses of the anabolic androgenic steroid, testosterone, on intermale aggression and sexual behavior in male rats, Physiol. Behav., 55, 331, 1994.
85. Breuer, M.E., McGinnis, M.Y., Lumia, A.R., and Possidente, B.P., Aggression in male rats receiving anabolic androgenic steroids: effects of social and environmental provocation, Horm. Behav., 40, 409, 2001.
86. McGinnis, M.Y., Lumia, A.R., Breuer, M.E., and Possidente, B., Physical provocation potentiates aggression in male rats receiving anabolic androgenic steroids, Horm. Behav., 41, 101, 2002.
87. McGinnis, M.Y., Lumia, A.R., and Possidente, B., Effects of withdrawal from anabolic androgenic steroids on aggression in adult male rats, Physiol. Behav., 75, 541, 2002.
88. Clark, A.S. and Barber, D.M., Anabolic-androgenic steroids and aggression in castrated male rats, Physiol. Behav., 56, 1107, 1994.
89. Melloni, R.H., Jr. and Ferris, C.F. Adolescent anabolic steroid use and aggressive behavior in golden hamsters, Ann. N.Y. Acad. Sci., 794, 372, 1996.
90. Melloni, R.H., Jr. et al., Anabolic-androgenic steroid exposure during adolescence and aggressive behavior in golden hamsters, Physiol. Behav., 61, 359, 1997.
91. B agonist progabide are differentially blocked by GABA receptor antagonists, Psychopharmacology, 129, 27, 1997.
92. Pfaff, D.W., Schwartz-Giblin, S., McCarthy, M.M., and Kow, L.-M., Cellular and molecular mechanisms of female reproductive behaviors, in The Physiology of Reproduction, Vol. 2, Knobil, E. and Neill, J.D., Eds., Raven Press Ltd., New York, 1994, chap 36.
93. A receptor γ subunit mRNAs in sexually dimorphic regions of the rat brain, Proc. R. Soc. Lond. B, 265, 1853, 1998.
94. Blasberg, M.E. and Clark, A.S., Anabolic-androgenic steroid effects on sexual receptivity in ovariectomized rats, Horm. Behav., 32, 201, 1997.
95. Clark, A.S., Blasberg, M.E., and Brandling-Bennett, E.M., Stanozolol, oxymetholone, and testosterone cypionate effects on the rat estrous cycle, Physiol. Behav., 63, 287, 1998.
96. Blasberg, M.E., Robinson, S., Henderson, L.P., and Clark, A.S., Inhibition of estrogen- induced sexual receptivity by androgens, Horm. Behav., 34, 283, 1998.